Graham G. Walmsley, a director at Akero Therapeutics, Inc. (NASDAQ:AKRO), recently acquired a significant amount of the company's common stock. According to a recent SEC filing, Walmsley purchased 200 ...

In a report released yesterday, Owen Lau from Oppenheimer maintained a Buy rating on Equifax (EFX – Research Report), with a price target of ...

Unions and the Economic Policy Institute filed suit in federal district court in Washington, D.C., to keep Musk and DOGE out of U.S. Labor Department files, following a suit by the Alliance for ...

In a report released today, Shlomo Rosenbaum from Stifel Nicolaus maintained a Buy rating on Equifax (EFX – Research Report), with a price ...

Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsTrevor Burns - Senior Vice President, Head ...

Shares of Equifax Inc. EFX slipped 8.42% to $247.48 Thursday, on what proved to be an all-around mixed trading session for ...

Equifax Inc. EFX has reported mixed fourth-quarter 2024 results, wherein earnings surpassed the Zacks Consensus Estimate, ...

Credit ratings firm Equifax's fourth-quarter revenue fell short of estimates, hurt by a weaker hiring market and ...

Equifax Inc. (EFX) on Thursday reported fourth-quarter net income of $174 million. On a per-share basis, the Atlanta-based company said it had net income of $1.39.

Greenleaf Trust increased its position in shares of Equifax Inc. (NYSE:EFX – Free Report) by 2.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm ...

Chicago Partners Investment Group LLC decreased its position in shares of Equifax Inc. (NYSE:EFX – Free Report) by 35.8% ...